1. Home
  2. BGT vs LFCR Comparison

BGT vs LFCR Comparison

Compare BGT & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGT
  • LFCR
  • Stock Information
  • Founded
  • BGT 2004
  • LFCR 1986
  • Country
  • BGT United States
  • LFCR United States
  • Employees
  • BGT N/A
  • LFCR N/A
  • Industry
  • BGT Trusts Except Educational Religious and Charitable
  • LFCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGT Finance
  • LFCR Health Care
  • Exchange
  • BGT Nasdaq
  • LFCR Nasdaq
  • Market Cap
  • BGT 320.3M
  • LFCR 308.8M
  • IPO Year
  • BGT N/A
  • LFCR N/A
  • Fundamental
  • Price
  • BGT $12.51
  • LFCR $7.61
  • Analyst Decision
  • BGT
  • LFCR Buy
  • Analyst Count
  • BGT 0
  • LFCR 4
  • Target Price
  • BGT N/A
  • LFCR $8.00
  • AVG Volume (30 Days)
  • BGT 107.2K
  • LFCR 108.3K
  • Earning Date
  • BGT 01-01-0001
  • LFCR 08-07-2025
  • Dividend Yield
  • BGT 10.77%
  • LFCR N/A
  • EPS Growth
  • BGT N/A
  • LFCR N/A
  • EPS
  • BGT N/A
  • LFCR N/A
  • Revenue
  • BGT N/A
  • LFCR $128,867,000.00
  • Revenue This Year
  • BGT N/A
  • LFCR $4.78
  • Revenue Next Year
  • BGT N/A
  • LFCR $12.02
  • P/E Ratio
  • BGT N/A
  • LFCR N/A
  • Revenue Growth
  • BGT N/A
  • LFCR 0.47
  • 52 Week Low
  • BGT $10.89
  • LFCR $3.68
  • 52 Week High
  • BGT $13.42
  • LFCR $8.85
  • Technical
  • Relative Strength Index (RSI)
  • BGT 51.65
  • LFCR 53.94
  • Support Level
  • BGT $12.37
  • LFCR $7.33
  • Resistance Level
  • BGT $12.55
  • LFCR $7.73
  • Average True Range (ATR)
  • BGT 0.10
  • LFCR 0.30
  • MACD
  • BGT 0.01
  • LFCR 0.03
  • Stochastic Oscillator
  • BGT 76.73
  • LFCR 65.33

About BGT BlackRock Floating Rate Income Trust

Blackrock Floating Rate Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income. The company's secondary investment objective is to seek the preservation of capital. The Trust seeks to achieve its investment objectives by investing mainly, under normal conditions, at least 80% of its assets in floating and variable rate instruments of U.S. and non-U.S. issuers, including a substantial portion of its assets in floating and variable rate securities including senior secured floating rate loans made to corporate and other business entities.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

Share on Social Networks: